Premium
Aptevo Therapeutics Inc (APVO)
NASDAQ
Hot Features
Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed us... Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.09 | 3.11418685121 | 2.89 | 3.2 | 2.89 | 184597 | 3.00948884 | CS |
| 4 | -1.17 | -28.1927710843 | 4.15 | 13.1099 | 2.81 | 7414046 | 5.02205508 | CS |
| 12 | -19.42 | -86.6964285714 | 22.4 | 27 | 2.81 | 5726823 | 7.48487277 | CS |
| 26 | -91.82 | -96.8565400844 | 94.8 | 100.4 | 2.81 | 3660397 | 14.85560172 | CS |
| 52 | -215.246 | -98.6344431919 | 218.226 | 485.366 | 2.81 | 5039519 | 197.64763289 | CS |
| 156 | -132516.22 | -99.9977512693 | 132519.2 | 234432 | 2.81 | 1950549 | 5362.31096855 | CS |
| 260 | -244522.62 | -99.9987813137 | 244525.6 | 1953600 | 2.81 | 1459384 | 113991.284019 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
